Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.72 USD | -4.44% |
|
-11.34% | -59.05% |
05-20 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
05-17 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.05% | 4.26M | |
+23.13% | 46.93B | |
+37.23% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- ENTO Stock
- News Entero Therapeutics, Inc.
- AzurRx BioPharma, Inc. Appoints Gregory Oakes to the Board of Directors, Effective April 13, 2020